Source: BioPortfolio

Polaris: Polaris Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14092017 Prices from USD $250

SummaryPolaris Pharmaceuticals Inc Polaris is a biopharmaceutical company that conducts research and development of protein drugs for the treatment of cancer and other enervating diseases. The company's ADIPEG 20 is a biotherapeutic agent which is being as...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Steve J.P. Hsu's photo - CEO of Polaris

CEO

Steve J.P. Hsu

CEO Approval Rating

- -/100

Read more